Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies.

Sperling MR, French J, Jacobson MP, Pazdera L, Gough M, Cheng H, Grinnell T, Blum D, Study 045 and 046 Investigators

DOI: 10.1212/wnl.0000000000002497
Published: 2016 Mar 22
Container: Neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1212/wnl.0000000000002497,
  title = {Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies.},
  author = {Sperling MR and French J and Jacobson MP and Pazdera L and Gough M and Cheng H and Grinnell T and Blum D and Study 045 and 046 Investigators},
  year = {2016},
  journal = {Neurology},
  doi = {10.1212/wnl.0000000000002497},
  url = {https://doi.org/10.1212/wnl.0000000000002497}
}

RIS

TY  - JOUR
TI  - Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies.
AU  - Sperling MR
AU  - French J
AU  - Jacobson MP
AU  - Pazdera L
AU  - Gough M
AU  - Cheng H
AU  - Grinnell T
AU  - Blum D
AU  - Study 045 and 046 Investigators
PY  - 2016
JO  - Neurology
DO  - 10.1212/wnl.0000000000002497
UR  - https://doi.org/10.1212/wnl.0000000000002497
ER  -

APA

MR, S., J, F., MP, J., L, P., M, G., H, C., T, G., D, B., & Investigators, S. 0. A. 0. (2016). Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies.. Neurology. https://doi.org/10.1212/wnl.0000000000002497

Source records

pubmed · retrieved 2026-09-26T16:57:19.943Z